Objective To observe the ultrasonic manifestations and age distribution of internal abdominal hernia in children.Methods Data of 53 children with internal abdominal hernia confirmed by operation were retrospectively a...Objective To observe the ultrasonic manifestations and age distribution of internal abdominal hernia in children.Methods Data of 53 children with internal abdominal hernia confirmed by operation were retrospectively analyzed.The ultrasonic findings were observed,and the age distribution of children was analyzed.Results Among 53 cases,"cross sign"was observed in 22 cases(22/53,41.51%),and"hernia ring beak sign"was detected in 26 cases(26/53,49.06%)by preoperative ultrasound,according to which 21 cases were diagnosed as internal abdominal hernia,with the accuracy of 39.62%(21/53).Meanwhile,manifestations of intestinal obstruction were noticed in 48 cases(48/53,90.57%),and intestinal necrosis was considered in 22 cases(22/53,41.51%).Four cases were misdiagnosed as intestinal perforation,appendicitis,intestinal atresia and volvulus,each in 1 case.The onset age of postoperative adhesive band internal hernia was larger than that of mesenteric hiatal hernia(P<0.05),while no significant difference of onset age was found among other types of internal abdominal hernias(all P>0.05).Intestinal ischemic necrosis was found in 25 cases,while the incidence of intestinal necrosis in children aged≤1 year,>1 and≤3 years,>3 and≤7 years and those>7 years was 66.67%(12/18),33.33%(4/12),36.36%(4/11)and 41.67%(5/12),respectively.Conclusion The characteristic ultrasonic findings of internal abdominal hernia in children included"cross sign"and"hernia ring beak sign".Internal abdominal hernia in children under 1 year had high risk of intestinal necrosis.展开更多
【目的】探讨黄芪甲苷对糖尿病肾病大鼠的治疗作用及机制。【方法】将27只大鼠随机分为正常组、模型组、黄芪甲苷组,每组9只。模型组、黄芪甲苷组大鼠给予高脂饲料喂养联合链脲佐菌素(STZ)40 mg/kg腹腔注射构建2型糖尿病肾病模型。造模...【目的】探讨黄芪甲苷对糖尿病肾病大鼠的治疗作用及机制。【方法】将27只大鼠随机分为正常组、模型组、黄芪甲苷组,每组9只。模型组、黄芪甲苷组大鼠给予高脂饲料喂养联合链脲佐菌素(STZ)40 mg/kg腹腔注射构建2型糖尿病肾病模型。造模成功后,黄芪甲苷组给予黄芪甲苷40 mg/kg灌胃治疗,正常组、模型组给予等体积生理盐水,每日1次,持续12周。12周后,测定大鼠空腹血糖(FBG)、尿白蛋白/尿肌酐比值(UACR)、血尿素氮(BUN)、血清肌酐(SCr)水平;苏木素-伊红(HE)染色法观察肾脏病理结构变化;过碘酸雪夫(PAS)染色、马松(Masson)染色法观察肾脏纤维化程度;定量聚合酶链反应(qPCR)、蛋白免疫印迹(Western Blot)法检测肾脏组织中腺苷酸蛋白活化激酶(AMPK)、内皮型一氧化氮合酶(e NOS)mRNA及蛋白表达水平。【结果】与模型组比较,黄芪甲苷组大鼠FBG、UACR显著降低(P<0.05),BUN、SCr含量未见明显改变;与模型组比较,黄芪甲苷组大鼠肾小球体积减小,基底膜增厚、系膜基质增生、肾小囊腔狭窄程度、胶原纤维沉积明显减轻;进一步的实验结果显示,黄芪甲苷组肾脏组织中AMPK、e NOS m RNA表达水平较模型组明显升高(P<0.05),AMPK的磷酸化水平及eNOS蛋白表达水平较模型组明显上调(P<0.05)。【结论】黄芪甲苷可改善大鼠糖尿病肾损害,其机制可能与激活AMPK/eNOS信号通路有关。展开更多
文摘Objective To observe the ultrasonic manifestations and age distribution of internal abdominal hernia in children.Methods Data of 53 children with internal abdominal hernia confirmed by operation were retrospectively analyzed.The ultrasonic findings were observed,and the age distribution of children was analyzed.Results Among 53 cases,"cross sign"was observed in 22 cases(22/53,41.51%),and"hernia ring beak sign"was detected in 26 cases(26/53,49.06%)by preoperative ultrasound,according to which 21 cases were diagnosed as internal abdominal hernia,with the accuracy of 39.62%(21/53).Meanwhile,manifestations of intestinal obstruction were noticed in 48 cases(48/53,90.57%),and intestinal necrosis was considered in 22 cases(22/53,41.51%).Four cases were misdiagnosed as intestinal perforation,appendicitis,intestinal atresia and volvulus,each in 1 case.The onset age of postoperative adhesive band internal hernia was larger than that of mesenteric hiatal hernia(P<0.05),while no significant difference of onset age was found among other types of internal abdominal hernias(all P>0.05).Intestinal ischemic necrosis was found in 25 cases,while the incidence of intestinal necrosis in children aged≤1 year,>1 and≤3 years,>3 and≤7 years and those>7 years was 66.67%(12/18),33.33%(4/12),36.36%(4/11)and 41.67%(5/12),respectively.Conclusion The characteristic ultrasonic findings of internal abdominal hernia in children included"cross sign"and"hernia ring beak sign".Internal abdominal hernia in children under 1 year had high risk of intestinal necrosis.
文摘【目的】探讨黄芪甲苷对糖尿病肾病大鼠的治疗作用及机制。【方法】将27只大鼠随机分为正常组、模型组、黄芪甲苷组,每组9只。模型组、黄芪甲苷组大鼠给予高脂饲料喂养联合链脲佐菌素(STZ)40 mg/kg腹腔注射构建2型糖尿病肾病模型。造模成功后,黄芪甲苷组给予黄芪甲苷40 mg/kg灌胃治疗,正常组、模型组给予等体积生理盐水,每日1次,持续12周。12周后,测定大鼠空腹血糖(FBG)、尿白蛋白/尿肌酐比值(UACR)、血尿素氮(BUN)、血清肌酐(SCr)水平;苏木素-伊红(HE)染色法观察肾脏病理结构变化;过碘酸雪夫(PAS)染色、马松(Masson)染色法观察肾脏纤维化程度;定量聚合酶链反应(qPCR)、蛋白免疫印迹(Western Blot)法检测肾脏组织中腺苷酸蛋白活化激酶(AMPK)、内皮型一氧化氮合酶(e NOS)mRNA及蛋白表达水平。【结果】与模型组比较,黄芪甲苷组大鼠FBG、UACR显著降低(P<0.05),BUN、SCr含量未见明显改变;与模型组比较,黄芪甲苷组大鼠肾小球体积减小,基底膜增厚、系膜基质增生、肾小囊腔狭窄程度、胶原纤维沉积明显减轻;进一步的实验结果显示,黄芪甲苷组肾脏组织中AMPK、e NOS m RNA表达水平较模型组明显升高(P<0.05),AMPK的磷酸化水平及eNOS蛋白表达水平较模型组明显上调(P<0.05)。【结论】黄芪甲苷可改善大鼠糖尿病肾损害,其机制可能与激活AMPK/eNOS信号通路有关。
基金Supported by National Natural Science Foundation of China(No.61773249)the Science and Technology on Near-Surface Detection Laboratory(No.6142414090117,No.TCGZ2017A006)~~